| Bioactivity | Bromodomain inhibitor-9 is a Bromodomains inhibitor that selectively inhibits BRD4-1 (Kd: 12 nM). Bromodomain inhibitor-9 can be used in the research of diseases or conditions associated with systemic or tissue inflammation, lipid metabolism, fibrosis or chronic autoimmune diseases[1]. |
| Invitro | Bromodomain inhibitor-9 (Compound 99, 1 h) inhibits LPS induced cytokines (IL12P40) release in PBMCs, with an IC50 value of 400 nM[1]. |
| Name | Bromodomain inhibitor-9 |
| CAS | 1870849-34-5 |
| Formula | C24H28N4O5S |
| Molar Mass | 484.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gerner Seitzberg, et al. Heterocyclic compounds as inhibitors of bromodomains and their preparation. Patent WO2016016316. |
Bromodomain inhibitor-9
CAS: 1870849-34-5 F: C24H28N4O5S W: 484.57
Bromodomain inhibitor-9 is a Bromodomains inhibitor that selectively inhibits BRD4-1 (Kd: 12 nM). Bromodomain inhibitor-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.